Latest episodes of the podcast CME
Mostrando página 12 de 21
Defining the Standard of Care and Optimal Sequencing in BRAF-Mutant mCRC: Second Line and Beyond
31/03/2025
Proactive Adverse Effect Management in mCRC: Improving Tolerability to Optimize Patient Outcomes
31/03/2025
Advancing Molecular Therapies to First Line in BRAF-Mutated mCRC: Insights From Emerging Data
24/07/2025
Antibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
26/03/2025
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
25/03/2025
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
25/03/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.